Radioactive diagnostic agent and its preparation

• US 4,444,743 A
• Filed: 09/15/1981
• Issued: 04/24/1984
• Est. Priority Date: 09/15/1981
• Status: Expired due to Fees

• Current Assignee: Nihon Medi-Physics Company Limited
• Original Assignee: Nihon Medi-Physics Company Limited
• Inventors: Yamada, Akira, Yokoyama, Akira, Tanaka, Hisashi, Arano, Yasushi
• Primary Examiner(s): Nucker, Christine M.
• Application Number:
  US06/302,563
• Time in Patent Office: 952 Days
• Field of Search: 564/19, 424/1, 424/1.5, 424/9
• US Class Current: 424/1.73
• CPC Class Codes: A61K 2123/00 Preparations for testing in vivo
• CPC Class Codes: A61K 51/0491 Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers

Abstract

A radioactive diagnostic agent for imaging of various organs, particularly of brain, which comprises a radioactive element such as ^99m TC and a non-radioactive carrier comprising as the essential component glucosone-bis(thiosemecarbazone) of the formula: ##STR1##

Claims

1. A radioactive diagnostic agent, comprising:

a chelate of glucosone-bis(thio-semicarbazone), of the formula;

##STR3## and a radioactive element selected from the group consisting of indium, galium and technetium.

2. A radioactive diagnostic composition suitable for use in medical diagnosis, comprising:

a chelate of glucosone-bis(thio-semicarbazone) according to claim 1, and a pharmaceutically acceptable carried therefor

3. The composition of claim 2, which further includes an oxidizing agent.

4. The composition of claim 3, which further includes a reducing agent.

5. The composition of claim 2, in the form of an aqueous solution.

6. The composition of claim 2, in the form of a lyophilized powder.

7. A method for imaging body organs, comprising the step of:

administering to said body a composition comprising a radioactive diagnostic agent chelate compound which includes a non-radioactive carrier having as an essential component glucosone-bis(thiocarbazone) of the formula;

##STR4## and a radioactive element; and

a pharmaceutically acceptable carier therefor; and

imaging said body organs.

8. A method according to claim 7, wherein said composition contains a reducing agent.

9. The method according to claim 7, wherein said composition contains an oxidizing agent.

10. The method according to claim 7, which comprises the step of imaging the brain of said body.

11. The method according to claim 8, which comprises the step of imaging the brain of said body.

12. The method according to claim 9, which comprises the step of imaging the brain of said body.

13. The method according to claim 7, wherein said radioactive element is selected from the group consisting of indium, galium and technetium.